logo

AGIO

AgiosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AGIO Profile

Agios Pharmaceuticals, Inc.

A leader in the field of cellular metabolism to treat rare and genetically defined diseases

Biological Technology
08/07/2007
07/24/2013
NASDAQ Stock Exchange
486
12-31
Common stock
88 Sidney Street, Cambridge, MA 02139
--
Agios Pharmaceuticals, Inc., was incorporated in Delaware on August 7, 2007. The company is a biopharmaceutical company dedicated to transforming patients' lives through leadership in cell metabolism, with the goal of creating differentiated medicines for rare diseases, with a focus on classical hematology.